The American College of Radiology (ACR), as a member of a coalition of leading medical societies, provided peripheral arterial disease (PAD) treatment recommendations to the Medicare Evidence Development Coverage Advisory Committee (MEDCAC).

As chronic traumatic encephalopathy (CTE) stands in the national spotlight for high impact sports, the University of California, Irvine has partnered with Toshiba America Medical Systems Inc. for a first-of-its-kind study of cerebral microbleeds (CMB) in high school football players as a potential precursor to CTE.

Focal Therapeutics, makers of the three-dimensional BioZorb implant used in breast conservation therapy, announced it has launched BioZorb LP.

The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6 billion by 2022, according to research and consulting firm GlobalData. This represents a compound annual growth rate of 4.9 percent.

The U.S. Food and Drug Administration (FDA) has received a small number of reports of adverse events that are believed to be associated with computed tomography (CT) imaging of some implantable and wearable electronic devices.

Using positron emission tomography (PET) to guide chemotherapy treatment significantly increases the number of people with advanced Hodgkin lymphoma who go into remission, according to new research.

iCAD Inc. announced that its mammography computer-aided detection (CAD) solution is now available on Fujifilm’s Aspire Cristalle full field digital mammography system.

The Centers for Medicare & Medicaid Services (CMS) announced its largest-ever initiative to transform and improve how primary care is delivered and paid for in America.

Prostate cancer patients and their doctors may want to think twice about the best timing for chemotherapy or radiation therapy in conjunction with a common nonsurgical treatment, based on international research findings.

April 8, 2016 — Wide variability exists in radiation treatment decisions following neoadjuvant chemotherapy (NAC) and ...